## BXP: BXP, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -0.5% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($68.69)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Boston Properties (BXP) insider plans Rule 144 sale of 36,314 common shares on NYSE**
- Source: Stock Titan | 20251201T121400 | Neutral | Relevance: 98%
- An insider at Boston Properties (BXP) plans to sell 36,314 shares of common stock under Rule 144 through Charles Schwab Corporation on the NYSE. The aggregate market value of the shares is reported as $2,619,873.00, with 158,468,685 shares of common stock outstanding. The shares were acquired on November 26, 2025, through redemption transactions of units in Boston Properties Limited Partnership.

**2. Assessing Boston Properties (BXP) Valuation After Recent Share Price Uptick**
- Source: Simply Wall Street | 20251202T010717 | Somewhat-Bullish | Relevance: 98%
- Boston Properties (BXP) has seen a recent share price uptick, yet its stock remains below its year-start price, reflecting challenges in the commercial property sector. Despite a negative one-year return, BXP shows healthy long-term recovery with a 27% 3-year total shareholder return and is considered 9.8% undervalued by market watchers, trading at $71.97 against a $79.80 fair value. The company's strategy of capital recycling, asset sales, and redevelopment aims to unlock higher-yielding income streams and fortify margins, driving future FFO and earnings resilience, though risks from declining occupancy remain.

**3. Assessing Boston Properties (BXP) Valuation After Recent Share Price Uptick**
- Source: Sahm | 20251202T230728 | Somewhat-Bullish | Relevance: 98%
-  Boston Properties (BXP) has seen a recent uptick in its stock price, though it remains below its year-start level, reflecting challenges in the commercial property sector. Despite this, the company shows a healthy longer-term recovery with a 3-year total shareholder return of nearly 27%. Analysts suggest BXP is undervalued with a fair value of $79.80, supported by its capital recycling strategy and expected rebound in profitability.

**4. Assessing Boston Properties (BXP) Valuation After Recent Share Price Uptick**
- Source: Simply Wall Street | 20251202T005929 | Somewhat-Bullish | Relevance: 97%
- Boston Properties (BXP) has seen a recent share price uptick, yet remains below its year-start valuation, reflecting challenges in the commercial property sector. Despite short-term struggles, BXP shows a healthy long-term recovery with a 3-year total shareholder return of nearly 27% and is considered 9.8% undervalued by market watchers, with a fair value of $79.80. The company's strategy of capital recycling, asset sales, and redevelopment aims to unlock higher-yielding income streams and fortify net margins.

**5. New York State Common Retirement Fund Purchases 2,930 Shares of BlackRock $BLK**
- Source: MarketBeat | 20251130T123541 | Neutral | Relevance: 65%
- The New York State Common Retirement Fund increased its stake in BlackRock by 1.5%, purchasing an additional 2,930 shares, bringing its total ownership to 204,742 shares valued at approximately $214.8 million. Wall Street analysts maintain a "Moderate Buy" rating with an average target price of $1,302.59, while director Rachel Lord sold 12,000 shares, reducing her holding by 62.48%. BlackRock also announced a quarterly dividend of $5.21 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Keybanc | $80 | $0 | 0% |
| 2025-12-01 | Barclays | $78 | $79 | -1% |
| 2025-11-25 | Wells Fargo | $74 | $77 | -4% |
| 2025-11-14 | Evercore ISI Gr | $76 | $77 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Keybanc | up | Overweight |
| 2025-12-01 | Barclays | main | Equal-Weight |
| 2025-11-25 | Wells Fargo | main | Overweight |
| 2025-11-14 | Evercore ISI Gr | main | In-Line |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.20M) |
| Sells | 6 ($5.11M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 15.2% (-1.4%)
- Blackrock Inc.: 11.2% (-8.7%)
- Tudor Investment Cor: 7.6% (+158588.2%)
- State Street Corpora: 7.1% (-1.1%)
- Cohen & Steers Inc.: 6.9% (+112.6%)

### Key Risks

1. Insider selling cluster: $5.1M in recent transactions.
2. Elevated short interest (8.8%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.29 indicates undervaluation relative to growth. Forward P/E 35.1x attractive for 184% earnings growth. Analyst sentiment negative (3 target cuts vs 1 raises). Insider selling cluster ($5.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.4B |
| Beta | 1.01 |
| 52W Range | $54.22 - $81.96 |
| Short Interest | 8.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.29 |
| Forward P/E | 35.1 |
| Current P/E | 99.7 |
| YoY Growth | 184.4% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 3.0% to -0.5% (-3.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.5pp (needs >4.0% for momentum thesis). RSI neutral at 52.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.46% (CS: 54) | Neutral |
| RSI_14 | 52.0 | Neutral |
| MACD Histogram | 0.30 | Bullish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 0.995x | Below |
| vs SMA200 | 1.036x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $71.75
- **Stop Loss:** $68.69 (4.3% risk)
- **Target:** $74.81 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 163
- **Position Value:** $11,695.25
- **Portfolio %:** 11.70%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-27 (Est: $0.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $-0.36 | -194.0% |
| 2025Q2 | $0.42 | $0.56 | +33.6% |
| 2025Q1 | $0.33 | $0.40 | +22.5% |
| 2024Q4 | $0.44 | $0.71 | +59.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*